Evidence map›Paper›PMID 41390775›Full record

ArticleNPJ Parkinson's disease2025

Optogenetic-induced α-synuclein accumulation reveals early synaptic dysfunction in experimental models of Parkinson's disease.

Raquel Rodriguez-Aller, Beatriz Romero-Quineche, Marc Morissette, Razan Sheta, Thérèse Di Paolo, Armen Saghatelyan, Abid Oueslati

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Raquel Rodriguez-AllerDepartment of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada.
Beatriz Romero-QuinecheDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Marc MorissetteCHU de Québec Research Center, Axe Neurosciences, Quebec City, QC, Canada.
Razan ShetaCHU de Québec Research Center, Axe Neurosciences, Quebec City, QC, Canada.
Thérèse Di PaoloCHU de Québec Research Center, Axe Neurosciences, Quebec City, QC, Canada.
Armen SaghatelyanDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. asaghate@uottawa.ca.
Abid OueslatiDepartment of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada. abid.oueslati.1@ulaval.ca.

Funding

CIHR FRN162400CIHR PJT 159680CIHR PJT 186027
6 · The paper itself

Abstract

Presynaptic accumulation of misfolded α-synuclein (α-syn) and altered synaptic transmission are considered early events in the pathogenesis of Parkinson's disease (PD), suggesting a potential causal link between these two events. However, the mechanisms by which α-syn aggregation induces synaptic dysfunction and the subsequent progressive neurodegeneration remain elusive. In the present study we leveraged the high temporal resolution of the Light-Inducible Protein Aggregation (LIPA) system in vivo and in human dopaminergic neurons to explore the early sequence of α-syn-induced pathological events leading to synaptopathy. We observed that nigrostriatal axonal transport and presynaptic accumulation of α-syn aggregates altered the activity of different neuronal populations in the mouse striatum. The results of histological and metabolite analyses show that presynaptic accumulation of α-syn induced a shift in the activation pattern of D1- and D2-expressing striatal medium spiny neurons, caused an increase in the size and density of dopaminergic synapses, and disrupted striatal dopamine signaling. Altogether, our findings reveal that the accumulation of α-syn in dopaminergic terminals triggered early presynaptic impairments, which subsequently altered striatal neuronal activity. Our study provides new insights into the molecular mechanisms underlying early synaptopathy in PD.

Identifiers

PMID41390775
PMCPMC12738572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.